Covestro (1COV) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
30 Jun, 2026Opening remarks and agenda
AGM opened with reflections on global volatility, economic uncertainty, and the importance of adaptability.
The meeting was held virtually, with all formalities and technical arrangements explained in detail.
No requests for agenda additions or counter motions were received; all required documents were made available in advance.
Financial performance review
Despite challenging conditions, full-year targets for 2024 were met, with a 7.4% increase in volume sold.
Sales remained slightly below the previous year due to low prices; EBITDA was stable at €1.1 billion.
Net income was negative at €-266 million, resulting in no dividend for 2024.
Free operating cash flow was positive at €89 million, with strong Q4 performance.
Performance materials segment saw 12% revenue growth from higher volumes, but margins were pressured by low prices.
Solutions and specialty segment increased volumes by 4%, but sales declined due to lower prices.
Board and executive committee updates
Monique Buch appointed as new Chief Commercial Officer, succeeding Sucheta Govil in August 2025.
Several changes in the Supervisory Board, with new members appointed and retirements noted.
Supervisory Board supported the strategic direction and internal optimization efforts.
Latest events from Covestro
- EBITDA surged 64.4% to €669 million as margins improved despite lower sales.1COV
Q2 2026 - FY 2025 saw lower sales and earnings, but transformation and climate targets remain on track.1COV
Investor presentation - EBITDA fell 30.9% to €740m as strategic actions and XRG partnership offset weak demand.1COV
Q4 2025 (Media) - Sales and EBITDA declined, but strategic initiatives and cost savings support future growth.1COV
Q4 2025 - Sales and EBITDA fell in Q3 2025, with guidance cut and acquisitions advancing.1COV
Q3 2025 - ADNOC's €62/share offer and €1.17bn capital boost support growth, sustainability, and governance.1COV
Investor Update - Q3 volume growth offset price declines; FY 2024 outlook narrowed amid margin pressure.1COV
Q3 2024 - Volume growth offset by lower prices; earnings and guidance down, STRONG program and ADNOC talks underway.1COV
Q2 2024 - Stable EBITDA and volume growth offset price declines; XRG takeover and STRONG program drive outlook.1COV
Q4 2024